JP2024540537A5 - - Google Patents
Info
- Publication number
- JP2024540537A5 JP2024540537A5 JP2024529579A JP2024529579A JP2024540537A5 JP 2024540537 A5 JP2024540537 A5 JP 2024540537A5 JP 2024529579 A JP2024529579 A JP 2024529579A JP 2024529579 A JP2024529579 A JP 2024529579A JP 2024540537 A5 JP2024540537 A5 JP 2024540537A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- oligomer compound
- modified oligonucleotide
- modified
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163281057P | 2021-11-18 | 2021-11-18 | |
| US63/281,057 | 2021-11-18 | ||
| PCT/US2022/080113 WO2023092057A1 (en) | 2021-11-18 | 2022-11-18 | Compounds and methods for modulating progranulin expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540537A JP2024540537A (ja) | 2024-10-31 |
| JP2024540537A5 true JP2024540537A5 (enExample) | 2025-11-06 |
Family
ID=86397858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529579A Pending JP2024540537A (ja) | 2021-11-18 | 2022-11-18 | プログラニュリン発現を調節するための化合物及び方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250109396A1 (enExample) |
| EP (1) | EP4433591A1 (enExample) |
| JP (1) | JP2024540537A (enExample) |
| WO (1) | WO2023092057A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024321134A1 (en) | 2023-08-10 | 2026-02-19 | Harness Therapeutics Limited | Functional nucleic acid |
| WO2025104638A1 (en) * | 2023-11-17 | 2025-05-22 | Universita' Degli Studi Di Brescia | Antisense oligonucleotides for modulation of progranulin splicing |
| GB202401412D0 (en) | 2024-02-02 | 2024-03-20 | Harness Therapeutics Ltd | Functional nucleic acid |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007284651B2 (en) * | 2006-08-09 | 2014-03-20 | Institute For Systems Biology | Organ-specific proteins and methods of their use |
| CN106967799A (zh) * | 2017-03-24 | 2017-07-21 | 杭州艾迪康医学检验中心有限公司 | 检测btk基因突变的方法、寡核苷酸及其应用 |
| US12595479B2 (en) * | 2019-03-20 | 2026-04-07 | President And Fellows Of Harvard College | Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases |
| WO2021229036A1 (en) * | 2020-05-13 | 2021-11-18 | F. Hoffmann-La Roche Ag | Oligonucleotide agonists targeting progranulin |
-
2022
- 2022-11-18 WO PCT/US2022/080113 patent/WO2023092057A1/en not_active Ceased
- 2022-11-18 JP JP2024529579A patent/JP2024540537A/ja active Pending
- 2022-11-18 US US18/710,928 patent/US20250109396A1/en active Pending
- 2022-11-18 EP EP22896756.8A patent/EP4433591A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540537A5 (enExample) | ||
| JP2022501040A5 (enExample) | ||
| JP2022520986A5 (enExample) | ||
| JP2024520205A5 (enExample) | ||
| JP2022536085A5 (enExample) | ||
| JP2022518929A5 (enExample) | ||
| JP4787409B2 (ja) | 治療用ホスホジエステラーゼ阻害剤 | |
| JP2010090159A (ja) | 腫瘍の治療における、ＴＧＦ−β、ＶＥＧＦ、インターロイキン−１０、Ｃ−ＪＵＮ、Ｃ−ＦＯＳまたはプロスタグランジンＥ２遺伝子にアンチセンスなオリゴヌクレオチドの低適用量の使用 | |
| JP2022533358A5 (enExample) | ||
| JP2024526953A (ja) | Ｕｎｃ１３ａアンチセンスオリゴヌクレオチド | |
| US20250051766A1 (en) | Treatment of neurological diseases using modulators of unc13a gene transcripts | |
| US20250099554A1 (en) | Compositions and methods of fas inhibition | |
| KR102526733B1 (ko) | 펩티드 핵산 복합체를 유효성분으로 함유하는 치매 예방 또는 치료용 조성물 | |
| JP2021534154A5 (enExample) | ||
| JP2024534157A5 (enExample) | ||
| EP2656850B1 (en) | Oligonucleotides for the treatment or alleviation of edema | |
| CN116814620A (zh) | 用于抑制syn2a的多核苷酸、含有其的外泌体及其用途 | |
| CN120659879A (zh) | Pikfyve反义寡核苷酸 | |
| KR20250138204A (ko) | Syf2 안티센스 올리고뉴클레오타이드 | |
| JPWO2019146805A1 (ja) | 前頭側頭葉変性症治療剤、前頭側頭葉変性症治療剤のスクリーニング方法、及び前頭側頭葉変性症の治療方法 | |
| JP2023532518A5 (enExample) | ||
| US20260098269A1 (en) | Compositions and methods for treatment of neuroinflammatory diseases | |
| JP2025517248A (ja) | ＳＣＮ１Ａ発現カセットのＣＡＶ－２媒介送達を介して外因性Ｎａｖ１．１活性を提供するためのベクター、組成物、及び方法 | |
| DE69835525T2 (de) | Verminderungsregulation der genexpression durch kolorektale verabreichung von synthetischen oligonukleotiden | |
| CN118475695A (zh) | Unc13a反义寡核苷酸 |